HLA DSA-SAB Class II IgG Antibodies with C1q Screen Test sale cost 7380 AED
HLA Single Antigen Bead Assay for Class I and II IgG Antibodies DSA-SAB Class I and II Test sale cost 9830 AED HLA Single Antigen Bead Assay for Class I and II IgG Antibodies DSA-SAB Class I and II Test Cost 10,920 د.إ Original price was: 10,920 د.إ.9,830 د.إCurrent price is: 9,830 د.إ.
HLA Typing- A B C DR and DQ Test for Donor and Recipient Test sale cost 5850 AED HLA Typing- A B C DR and DQ Test for Donor and Recipient Test Cost 6,500 د.إ Original price was: 6,500 د.إ.5,850 د.إCurrent price is: 5,850 د.إ.
Sale!

HLA DSA-SAB Class II IgG Antibodies with C1q Screen Test Cost

Original price was: 8,200 د.إ.Current price is: 7,380 د.إ.

-10%

The HLA DSA-SAB Class II IgG Antibodies with C1q Screen Test is a specialized diagnostic procedure aimed at identifying specific antibodies that can have a critical impact on organ transplant compatibility and success. HLA (Human Leukocyte Antigen) antibodies are part of the immune system’s response to perceived foreign entities. The presence of these antibodies can indicate a potential for organ rejection in transplant scenarios.

This test specifically targets the Class II IgG antibodies. These antibodies are directed against the donor’s HLA antigens, which can lead to complications in transplant recipients if not identified and managed properly. The inclusion of the C1q screen adds an additional layer of specificity by identifying antibodies capable of activating the complement system, which is a part of the immune system that enhances the ability of antibodies and phagocytic cells to clear pathogens from an organism. The activation of the complement system by these antibodies can lead to a higher risk of graft damage or loss.

Performed at DNA Labs UAE, a facility known for its advanced diagnostic technologies and expert staff, the test is priced at 7380 AED. Given the complexity and the specialized nature of the test, it represents a critical investment in the pre-transplant assessment process, helping to ensure that potential recipients have the highest chance of a successful transplant outcome by identifying and addressing immunological risks before they can impact the graft.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN Test

At DNA Labs UAE, we offer the HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN Test at a cost of AED 7380.0. This laboratory test is designed to detect the presence of HLA class II IgG antibodies in the blood.

Test Components and Price

  • Test Name: HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN Test
  • Price: 7380.0 AED

Sample Condition

For this test, we require a minimum of 2 mL serum from 1 SST. Please ship the sample refrigerated or frozen. Additionally, provide a brief clinical history and HLA typing report of the donor/donors if it is a pre or post transplantation sample.

Report Delivery

The test results will be delivered within 10-12 days.

Method

We utilize Luminex X-Map technology for conducting the HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN Test.

Test Type

This test falls under the category of transplantation pathology.

Doctor

This test is typically ordered by nephrologists and hematologists.

Test Department

This test is conducted in our dedicated Test Department.

Pre Test Information

Please provide a brief clinical history and HLA typing report of the donor/donors if it is a pre or post transplantation sample.

Test Details

The HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN Test is a laboratory test used to detect the presence of HLA class II IgG antibodies in the blood. These antibodies can be produced in response to organ transplantation or blood transfusion and can lead to rejection of the transplanted organ or transfused blood.

The test utilizes a solid-phase assay called the single antigen bead (SAB) assay to detect HLA antibodies. The beads in the assay contain specific HLA antigens, and if there are antibodies in the patient’s blood that recognize those antigens, they will bind to the beads. The test also includes a C1q screening step, which helps to identify clinically significant antibodies that are more likely to cause rejection of the transplanted organ or transfused blood.

The results of the test are reported as the presence or absence of HLA class II IgG antibodies and the strength of the antibody response. A positive result indicates that the patient has antibodies against specific HLA antigens, which may increase the risk of rejection of a transplanted organ or transfused blood. This information can be used by healthcare providers to select appropriate donors for transplantation or to monitor patients for rejection after transplantation.

Test Name HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN Test
Components
Price 7380.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Give brief clinical history and HLA typing report of Donor\/Donors if Pre or Post transplantation sample.
Report Delivery 10-12 days
Method Luminex X-Map technology
Test type Transplantation pathology
Doctor Nephrologist, Hematologist
Test Department:
Pre Test Information Give brief clinical history and HLA typing report of Donor/Donors if Pre or Post transplantation sample.
Test Details

The HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN Test is a laboratory test used to detect the presence of HLA (human leukocyte antigen) class II IgG antibodies in the blood. These antibodies can be produced in response to organ transplantation or blood transfusion and can lead to rejection of the transplanted organ or transfused blood.

The test uses a solid-phase assay called the single antigen bead (SAB) assay to detect HLA antibodies. The beads in the assay contain specific HLA antigens, and if there are antibodies in the patient’s blood that recognize those antigens, they will bind to the beads. The test also includes a C1q screening step, which helps to identify clinically significant antibodies that are more likely to cause rejection of the transplanted organ or transfused blood.

The results of the test are reported as the presence or absence of HLA class II IgG antibodies and the strength of the antibody response. A positive result indicates that the patient has antibodies against specific HLA antigens, which may increase the risk of rejection of a transplanted organ or transfused blood. This information can be used by healthcare providers to select appropriate donors for transplantation or to monitor patients for rejection after transplantation.

SKU: TEST-764 Category:

Related products